Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
52
SOLV Quote, Financials, Valuation and Earnings
Last price:
$80.17
Seasonality move
:
4.79%
Day range:
$80.01 - $80.70
52-week range:
$60.70 - $88.20
Dividend yield:
0%
P/E ratio:
9.27x
P/S ratio:
1.67x
P/B ratio:
2.80x
Volume:
752.8K
Avg. volume:
1.2M
1-year change:
20.46%
Market cap:
$14B
Revenue:
$8.3B
EPS (TTM):
$8.69
Analysts' Opinion
-
Consensus RatingSolventum Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 7 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $85.64, Solventum Corp. has an estimated upside of 6.32% from its current price of $80.18.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $71.00 representing 100% downside risk from its current price of $80.18.
Fair Value
-
According to the consensus of 11 analysts, Solventum Corp. has 6.32% upside to fair value with a price target of $85.64 per share.
SOLV vs. S&P 500
-
Over the past 5 trading days, Solventum Corp. has underperformed the S&P 500 by -2% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Solventum Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Solventum Corp. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Solventum Corp. reported revenues of $2.1B.
Earnings Growth
-
Solventum Corp. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Solventum Corp. reported earnings per share of $7.22.
Enterprise value:
17.5B
EV / Invested capital:
1.73x
Price / LTM sales:
1.67x
EV / EBIT:
16.83x
EV / Revenue:
2.07x
PEG ratio (5yr expected):
0.09x
EV / Free cash flow:
311.90x
Price / Operating cash flow:
251.68x
Enterprise value / EBITDA:
11.26x
Gross Profit (TTM):
$4.8B
Return On Assets:
10.46%
Net Income Margin (TTM):
18.08%
Return On Equity:
42.2%
Return On Invested Capital:
13.6%
Operating Margin:
8.16%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $8.2B | $8.2B | $8.4B | $2.1B | $2.1B | |
| Gross Profit | $3.5B | $4.6B | $4.8B | $1.2B | $1.1B | |
| Operating Income | $1.7B | $1.3B | $1B | $275M | $171M | |
| EBITDA | $2.2B | $1.9B | $1.6B | $408M | $285M | |
| Diluted EPS | $6.22 | $4.16 | $8.69 | $0.70 | $7.22 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $2.7B | $3.4B | $4.4B | |
| Total Assets | -- | -- | $13.9B | $14.7B | $14B | |
| Current Liabilities | -- | -- | $1.5B | $2.9B | $2.9B | |
| Total Liabilities | -- | -- | $10.6B | $11.6B | $9B | |
| Total Equity | -- | -- | $3.3B | $3.2B | $5B | |
| Total Debt | -- | -- | -- | $8.1B | $5.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $1.5B | $499M | $169M | $76M | |
| Cash From Investing | -- | -$341M | $3.4B | -$93M | $3.8B | |
| Cash From Financing | -- | -$442M | -$3.1B | -$202M | -$2.7B | |
| Free Cash Flow | -- | $1.2B | $56M | $76M | -$21M | |
SOLV
Sector
Market Cap
$14B
$28.1M
Price % of 52-Week High
91.33%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
5.97%
-1.49%
1-Year Price Total Return
20.89%
-17.13%
Beta (5-Year)
--
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$80.78
200-day SMA
Buy
Level
$73.55
Bollinger Bands (100)
Buy
Level
70.1 - 79.72
Chaikin Money Flow
Buy
Level
744.2K
20-day SMA
Sell
Level
$82.71
Relative Strength Index (RSI14)
Sell
Level
48.68
ADX Line
Sell
Level
15.17
Williams %R
Buy
Level
-87.102
50-day SMA
Buy
Level
$77.14
MACD (12, 26)
Buy
Level
21.21
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
1.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.486)
Buy
CA Score
(Annual)
Level (0.1801)
Buy
Beneish M-Score
(Annual)
Level (-4.4747)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (2.0437)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.
Stock Forecast FAQ
In the current month, SOLV has received 3 Buy ratings 7 Hold ratings, and 1 Sell ratings. The SOLV average analyst price target in the past 3 months is $85.64.
-
Where Will Solventum Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Solventum Corp. share price will rise to $85.64 per share over the next 12 months.
-
What Do Analysts Say About Solventum Corp.?
Analysts are divided on their view about Solventum Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Solventum Corp. is a Sell and believe this share price will drop from its current level to $71.00.
-
What Is Solventum Corp.'s Price Target?
The price target for Solventum Corp. over the next 1-year time period is forecast to be $85.64 according to 11 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is SOLV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Solventum Corp. is a Hold. 7 of 11 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of SOLV?
You can purchase shares of Solventum Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Solventum Corp. shares.
-
What Is The Solventum Corp. Share Price Today?
Solventum Corp. was last trading at $80.17 per share. This represents the most recent stock quote for Solventum Corp.. Yesterday, Solventum Corp. closed at $80.18 per share.
-
How To Buy Solventum Corp. Stock Online?
In order to purchase Solventum Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SOLV Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SOLV
Sector
P/E ratio
9.27x
23.89x
PEG ratio
0.09x
-0.01x
P/B ratio
2.80x
1.81x
Price / LTM sales
1.67x
1.59x
Growth Metrics
SOLV
Sector
Revenue growth
0.67%
4.62%
Earnings growth
928.76%
11.06%
Revenue (5-year growth)
--
6.5%
Earnings forecast
$1.43
-$0.21
Profitability
SOLV
Sector
Profitability FY 2024
$4.6B
$3.6M
Return on invested capital
13.6%
-31.84%
Return on assets
10.46%
-27.96%
Return on equity
42.2%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
SOLV
Sector
Total cash
$1.6B
$26.4M
Short term investments
--
$25.7M
Total assets
$14.5B
$76.9M
Long term debt
$5.1B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
87
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
60
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
